Novartis’s Canakinumab Fails In COVID-19 Pneumonia Patients

Dexamethasone Remains Only Proven Therapy In Severe Disease

 
• By Andrew McConaghie

Drug fails to save lives in study and follows disappointments from Roche and Regeneron/Sanofi's IL-6 inhibitors.

Basel, Switzerland - 27 August, 2016: sign on the wall of a Novartis building. Novartis International AG is a Swiss pharmaceutical company based in Basel, Switzerland.
The trial aimed to help hospitalized patients not yet on mechanical ventilation but failed to show an impact on mortality rates. • Source: Archive

More from Business

More from Scrip